UH engineers helped develop an mRNA-based strategy that boosts cancer-fighting T cells and, in mouse studies, helped ...
Six days after Netflix dropped all eight episodes of The WONDERfools simultaneously on May 15, 2026, the South Korean ...
HTX-001 is a first-in-class antisense oligonucleotide designed to downregulate WISPER lncRNA, a driver of fibrosis in the heartPhase 1a/b trial to evaluate the safety and tolerability of HTX-001 in ...
HAYA Therapeutics doses first cohort in phase 1 clinical trial of HTX-001 for cardiac fibrosis: Lausanne, Switzerland Friday, May 22, 2026, 15:00 Hrs [IST] HAYA Therapeutics SA, a ...
For years, Silicon Valley treated ageing as a background fact of life rather than a technical problem. Wealth from the AI ...
Subset analysis shows early clinical activity supported by biomarker evidence of targeting cancer stem cell pathways driving tumor growth and progression CAMBRIDGE, United Kingdom, May 22, 2026 (GLOBE ...
Researchers at the Icahn School of Medicine at Mount Sinai, Bristol Myers Squibb, and the University of Oxford have ...
The electric-scooter maker said FY26 was a reset year focused on improving operations, margins and cell manufacturing, even ...
On Wednesday, the Bengaluru-based company posted a 50% year-on-year decline in FY26 revenue at ₹2,253 crore, well below its ...
Morning Overview on MSN
A new gene-editing treatment just drove back advanced stomach and colon cancers in an early trial — by reprogramming patients’ own immune cells to hunt the tumors
Twelve people whose stomach or colon cancers had defeated every available treatment were infused with their own immune cells, ...
Ola Electric reports Rs 265 cr revenue in Q4 FY26, Rs 2253 cr for FY26. Focus on service, cost reduction, and cell ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results